Qidan Maosheng: Building AstraZeneca's Globally Optimal Project


Qi'an Maosheng: Building AstraZeneca's Global Best Project

Mao Sheng International Engineering Branch is a flagship unit of Jiangsu Qian'an, and it has become a perennial leader in the foreign-invested sector, renowned throughout the industry for its outstanding professional expertise. Despite the currently challenging market conditions, Mao Sheng Branch continues to achieve remarkable success, securing numerous foreign-invested projects. This year, the team participated in AstraZeneca's inhalation aerosol project in Qingdao. AstraZeneca is a global biopharmaceutical company dedicated to the research, development, manufacturing, and sale of prescription drugs, with operations spanning over 100 countries worldwide. The Mao Sheng team was primarily responsible for mechanical and electrical installation, fire protection engineering, process engineering, cleanroom construction, epoxy flooring, and other critical tasks, with the contract value nearing 180 million yuan. As a typical foreign-invested project, AstraZeneca has exceptionally high and stringent requirements for safety, quality, and schedule. Stepping into the project site, one is immediately struck by the impressive scene of civilized construction—floors are impeccably clean and dust-free, materials are neatly arranged, comprehensive protective measures are rigorously in place, and every work process unfolds smoothly and efficiently. At the peak of construction, the site hosted over 400 workers, placing immense demands on project management and coordination, calling for seamless, collaborative efforts across all teams. The Maosheng team, with its world-class expertise and unwavering professionalism, has earned high praise from AstraZeneca’s management—from the meticulous BM design phase and factory-based prefabrication to the highly focused, lean construction approach. In September of this year, Pran, Global Engineering Director at AstraZeneca, made a special trip to Qingdao to inspect the project firsthand. He was thoroughly impressed, declaring it "the finest and most outstanding project" within AstraZeneca’s global portfolio! Speaking during an interview with the Group’s News Highlights team, Jie Ji, Project Manager of the general contractor and managing company, emphasized that both the general contractor and the client hold the Qian’an Maosheng team in great esteem. He confidently predicted that the two sides will undoubtedly explore even more opportunities for collaboration in the future.

Recommended news


Empowering Communities Through Health: Experts Bring Science-Based Education to Qian’an

On September 18, Jiangsu Qian’an Construction Group, in collaboration with the Science Education Base of Qidong People’s Hospital, hosted the 2026 National Science Popularization Event.


Benchmarking against global standards! The Jotun Zhangjiagang project has successfully passed the safety audit conducted by its Norwegian headquarters.

In mid-September, a foreign‑owned expert audit team from Jotun’s Norwegian headquarters conducted a three‑day, headquarter‑level specialized safety audit on the Jotun Zhangjiagang project site undertaken by the Group.


The Roche (Shanghai) project of the Group has successfully achieved 2 million safe man-hours.

On September 17, the Roche (Shanghai) Biopharmaceutical Production Base project, undertaken by the Group, successfully reached the milestone of 2 million safe man-hours.


The Group dispatched personnel to attend the training on building trustworthy quality teams in chemical engineering construction.

On September 16–17, the China Chemical Construction Enterprises Association held a training course on building “Quality‑Trusted Work Teams” in Chengdu, with representatives from the Group in attendance. The session featured a live lecture by Shi Jie, a senior expert of the Association.


Good News Abounds | The Group Has Secured Multiple Emerging Industry Projects in Succession

In the golden autumn season, bountiful harvests abound, and new‑generation growth sectors showcase their strength. Since August, leveraging its deep-rooted expertise and core competencies in industrial installation, the Group has successively won bids for five key projects in emerging productivity fields, with a total contract value exceeding RMB 250 million, injecting robust momentum into its resilient year‑end performance.


Two QC achievements of the Group have been awarded at the National Engineering Construction Quality Management Achievement Competition.

Recently, the China Construction Industry Association announced the results of the 2026 Engineering Construction Quality Management Team Achievement Competition. Two QC projects submitted by the Group—“Improving the First-Pass Acceptance Rate for One-Time Forming of Exterior Concrete Moldings” and “Enhancing the First-Pass Welding Acceptance Rate for Dissimilar Steels”—were awarded second and third prizes, respectively.